Postural Orthostatic Tachycardia Syndrome (POTS) is a disorder of autonomic nervous system regulation characterized by excessive heart rate increases upon standing, often accompanied by dizziness, palpitations, fatigue, brain fog, exercise intolerance, gastrointestinal symptoms, and impaired quality of life.
Over the past several years, researchers have increasingly recognized that many patients with POTS demonstrate an imbalance between the sympathetic ("fight-or-flight") and parasympathetic ("rest-and-digest") branches of the autonomic nervous system. This imbalance has led investigators to explore therapies designed to enhance vagal activity and restore autonomic regulation.
One of the most promising approaches is vagus nerve stimulation (VNS), particularly transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive technique that stimulates branches of the vagus nerve through the external ear. Recent studies have evaluated whether increasing vagal activity can improve autonomic function and reduce symptoms in patients with POTS.
The vagus nerve is the primary parasympathetic nerve of the body and plays an important role in regulating:
Multiple studies have demonstrated that patients with POTS often exhibit reduced parasympathetic activity and excessive sympathetic activation. This imbalance contributes to the exaggerated heart rate response and autonomic symptoms experienced during standing.
Researchers have proposed that increasing vagal activity may help restore autonomic balance and improve cardiovascular regulation in POTS.
Several mechanisms have been proposed to explain how vagal stimulation may improve symptoms.
Restoration of Sympathetic-Parasympathetic Balance
One of the primary theories is that vagal stimulation enhances parasympathetic activity while reducing excessive sympathetic nervous system activation.
Investigators have suggested that increasing vagal tone may improve autonomic balance and reduce the excessive cardiovascular responses that occur when patients stand upright.
Improvement in Heart Rate Regulation
POTS is characterized by excessive orthostatic tachycardia.
Studies evaluating vagal stimulation have demonstrated reductions in standing heart rate responses and improvements in measures of cardiac autonomic function. These findings suggest that vagal stimulation may improve the body's ability to regulate heart rate during orthostatic stress.
Reduction of Inflammatory Activity
Recent investigations have identified elevated inflammatory markers and immune abnormalities in some patients with POTS.
Researchers studying vagal stimulation observed reductions in inflammatory cytokines and decreases in markers associated with sympathetic activation. These findings support the concept that vagal stimulation may influence the inflammatory pathways involved in autonomic dysfunction.
Modulation of Autoimmune Mechanisms
Several studies have proposed that autoimmune processes may contribute to POTS in certain patients.
Investigators reported reductions in antiadrenergic autoantibodies following vagal stimulation, suggesting that neuromodulation may influence immune pathways involved in disease expression.
One of the most important studies evaluating vagal stimulation in POTS was a randomized controlled trial published in 2024.
Patients received daily transcutaneous auricular vagus nerve stimulation for two months. Researchers assessed heart rate responses, autonomic function, inflammatory markers, and symptom severity.
The study demonstrated that patients receiving active vagal stimulation experienced significant reductions in postural tachycardia compared with the sham treatment group. Improvements were also observed in measures of cardiac autonomic regulation. In addition, reductions in inflammatory cytokines and antiadrenergic autoantibodies were reported.
The investigators concluded that non-invasive vagal stimulation improved cardiovascular autonomic regulation and reduced orthostatic tachycardia in patients with POTS.
A 2025 systematic review evaluating available treatments for POTS reviewed emerging evidence for vagal stimulation and autonomic neuromodulation.
The review identified vagal stimulation as a promising non-pharmacologic intervention and highlighted growing evidence supporting improvements in autonomic regulation and symptom control. However, the authors emphasized that larger clinical trials and longer-term outcome studies remain necessary before definitive treatment recommendations can be made.
Across published studies, investigators have reported improvements in several symptom domains, including:
Researchers have consistently observed objective improvements in autonomic markers alongside reductions in symptom severity, supporting the hypothesis that vagal stimulation directly influences autonomic nervous system function.
The phrase "vagus nerve reset" is commonly used to describe the goal of restoring healthier autonomic nervous system function.
Within the scientific literature, this concept refers to improving parasympathetic activity, reducing excessive sympathetic activation, enhancing autonomic balance, and improving cardiovascular reflex control. Investigators studying vagal stimulation in POTS have demonstrated measurable changes in autonomic function that support this regulatory model.
Current evidence suggests that vagal stimulation may improve autonomic regulation in patients with POTS through multiple pathways, including enhancement of parasympathetic activity, reduction of sympathetic overactivity, modulation of inflammatory signaling, and improvement of cardiovascular reflex function.
The strongest evidence comes from randomized controlled studies demonstrating reductions in orthostatic tachycardia and improvements in autonomic markers. Systematic reviews describe the results as promising while emphasizing the need for larger studies to determine long-term effectiveness and identify which patients are most likely to benefit.
Current research supports the concept that vagal stimulation may improve autonomic dysfunction in POTS by enhancing parasympathetic activity and restoring autonomic balance. Clinical studies have demonstrated reductions in orthostatic tachycardia, improvements in autonomic regulation, and favorable changes in inflammatory and immune markers. These findings support continued investigation of vagal neuromodulation as a treatment strategy for patients with POTS.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10762669/
https://www.sciencedirect.com/science/article/abs/pii/S1071916425007493
https://link.springer.com/article/10.1007/s10286-025-01172-2
https://pmc.ncbi.nlm.nih.gov/articles/PMC7936931/
https://pubmed.ncbi.nlm.nih.gov/34144933/
https://pubmed.ncbi.nlm.nih.gov/30871704/
https://pubmed.ncbi.nlm.nih.gov/31412221/
https://pubmed.ncbi.nlm.nih.gov/32637119/
Copyright © 2026 NY 360 Wellness Medicine - All Rights Reserved.
NY 360 Wellness Medicine is a functional medicine and longevity clinic in New York specializing in hormone therapy, fatigue, weight management, gut health, and preventive Medicine 3.0 care. We provide personalized, physician-led treatment plans using advanced diagnostics and integrative therapies to help people achieve long-term health and vitality.
Become a part of the elite group of members who will be eligible for 15% off all membership tiers if you sign up before June 15th.
Use code: Founder